Protagonist Therapeutics (PTGX) Capital Expenditures (2015 - 2026)
Protagonist Therapeutics (PTGX) recorded Capital Expenditures of $168,000 in Q2 2026, down 79.3% from $813,000 a year earlier and down 21.9% from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Capital Expenditures (2015 - 2026) Analysis & Trends
On a TTM basis, Protagonist Therapeutics' Capital Expenditures came in at $615,000 as of Jun 30, 2026, down 74.8% year-over-year; for FY2025, it came in at $1.59 million, up 17.3% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 27.5% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $1.36 million in FY2024 (+122.5%), $609,000 in FY2023 (-23.4%), $795,000 in FY2022 (-27.8%) and $1.1 million in FY2021 (+133.8%).
- Quarterly Capital Expenditures has ranged from $10,000 in Q1 2023 to $813,000 in Q2 2025 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for four consecutive quarters, with an average decline of 10.8% over the last six quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 253.3% in Q3 2021, against a decline of 96.3% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $215,000 (Q1 2026), $144,000 (Q4 2025) and $88,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Protagonist Therapeutics | 9.11 Bn | 9.11 Bn | - | 168,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168,000.00 |
| Mar 31, 2026 | 215,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 813,000.00 |
| Mar 31, 2025 | 545,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Sep 30, 2024 | 775,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 242,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 404,000.00 |
| Jun 30, 2023 | 176,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 162,000.00 |
| Jun 30, 2022 | 290,000.00 |
| Mar 31, 2022 | 273,000.00 |
| Dec 31, 2021 | 196,000.00 |
| Sep 30, 2021 | 265,000.00 |
API Access
Protagonist Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();